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BACKGROUND: The sperm DNA methylation landscape is unique and critical for oﬀspring health. If gamete-derived DNA methylation escapes reprograming
in early embryos, epigenetic defects in sperm may be transmitted to the next generation. Current techniques to assess sperm DNA methylation show bias toward CpG-dense regions and do not target areas of dynamic methylation, those predicted to be environmentally sensitive and tunable regulatory elements.
OBJECTIVES: Our goal was to assess variation in human sperm DNA methylation and design a targeted capture panel to interrogate the human sperm
methylome.
METHODS: To characterize variation in sperm DNA methylation, we performed whole genome bisulﬁte sequencing (WGBS) on an equimolar pool of
sperm DNA from a wide cross section of 30 men varying in age, fertility status, methylenetetrahydrofolate reductase (MTHFR) genotype, and exposures. With our targeted capture panel, in individual samples, we examined the eﬀect of MTHFR genotype (n = 13 677CC, n = 8 677TT), as well as
high-dose folic acid supplementation (n = 6, per genotype, before and after supplementation).
RESULTS: Through WGBS we discovered nearly 1 million CpGs possessing intermediate methylation levels (20–80%), termed dynamic sperm CpGs. These
dynamic CpGs, along with 2 million commonly assessed CpGs, were used to customize a capture panel for targeted interrogation of the human sperm methylome and test its ability to detect eﬀects of altered folate metabolism. As compared with MTHFR 677CC men, those with the 677TT genotype (50% decreased
MTHFR activity) had both hyper- and hypomethylation in their sperm. High-dose folic acid supplement treatment exacerbated hypomethylation in MTHFR
677TT men compared with 677CC. In both cases, >80% of altered methylation was found in dynamic sperm CpGs, uniquely measured by our assay.
DISCUSSION: Our sperm panel allowed the discovery of diﬀerential methylation following conditions aﬀecting folate metabolism in novel dynamic
sperm CpGs. Improved ability to examine variation in sperm DNA methylation can facilitate comprehensive studies of environment–epigenome interactions. https://doi.org/10.1289/EHP4812

Introduction
A signiﬁcant decrease in sperm counts over the last 50 y has been
reported in men from Western countries, and environmental
exposures to developing male germ cells have been suggested as
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one of the potential causes (Barouki et al. 2018; Levine et al.
2017). Human and animal studies have demonstrated that various
paternal exposures, including environmental, diet, drug, and psychological stress, can have consequences for the next generation
(Carone et al. 2010; Lumey et al. 2007; Watkins and Sinclair
2014). Besides mutations and eﬀects directly on genomic
sequence, such exposures can reach measureable diﬀerences in
DNA methylation, histone posttranslational modiﬁcations and
small noncoding RNA expression (reviewed by Nilsson et al.
2018). DNA methylation undergoes well-characterized patterns
of erasure and reestablishment during male germ cell development, is unique in sperm as compared with somatic tissue, and is
a strong candidate for an epigenetic mark that can be altered, with
the resulting epimutations potentially transmitted to the next generation (Ly et al. 2015; Ziller et al. 2013). To accurately determine
how diﬀerent paternal exposures impact the sperm DNA methylome, there is a need to develop more comprehensive and costeﬀective approaches to assess the presence and transmissibility of
altered DNA methylation in sperm and its impact on the health of
future generations.
DNA methylation can aﬀect ∼30 million sites across the
human genome (Edwards et al. 2017), mainly occurring in a
5 0 -cytosine-phosphate-guanine-3 0 (CpG) dinucleotide context. In
male germ cells of the fetal testis, DNA methylation is erased in primordial germ cells and then reestablished, including at imprinted
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genes, in mitotically quiescent prospermatogonia between weeks
11 and 16 of gestation (Gkountela et al. 2015; Tang et al. 2015). It is
also at this time that a mother’s gestational exposure might impact
the germ cell epigenome of her male fetus (Wu et al. 2017a). At puberty, with the resumption of postnatal spermatogenesis, the majority of DNA methylation patterns acquired in prenatal germ cells
need to be maintained in dividing spermatogonia, but continuous
remodeling also occurs in meiotic spermatocytes and postmeiotic
spermatids (Gaysinskaya et al. 2018; Ly et al. 2015). Thus, spermatogenesis, taking about 3 months in men, is an ongoing process
and, as such, represents a window from puberty onward when the
male germ cell epigenome could be susceptible to environmental
insults.
Whole genome bisulﬁte sequencing (WGBS) provides comprehensive coverage of the epigenome. However, WGBS is challenging to adapt to large studies and, to date, only one human
sperm WGBS data set of >10 × genome-wide CpG coverage has
been published (Molaro et al. 2011). The Illumina® Inﬁnium
HumanMethylation450 BeadChip (450K) arrays are the most
commonly used approach to assess the methylation of human
sperm. With this approach, various factors including age (Jenkins
et al. 2014), smoking (Alkhaled et al. 2018; Jenkins et al. 2017;
Laqqan et al. 2017), phthalates (Wu et al. 2017b), and infertility
(Aston et al. 2015; Jenkins et al. 2016) have been reported to alter
the sperm DNA methylome. However, the 450K arrays provide
limited coverage of the epigenome and focus on genic and CpGrich regions. Reduced representation bisulﬁte sequencing (RRBS),
which targets primarily classical CpG islands and other high-GC
content sequences, and low coverage unbiased WGBS, were used
to examine sperm of men exposed to high-dose folic acid (Aarabi
et al. 2015) or dioxin (Pilsner et al. 2018), respectively. These
results suggest that intergenic regions and regions of intermediate
methylation (20–80%), where distal regulatory regions reside, may
be particularly susceptible to paternal exposures. Although the
newer Illumina® Inﬁnium MethylationEPIC BeadChip (850K)
arrays allow assessment of some intergenic and enhancer CpG
methylation sites, they are not speciﬁcally designed to interrogate
the specialized sperm epigenome.
Targeted capture sequencing panels oﬀer an alternative to
WGBS, allowing the customization needed to target the sperm
epigenome with enrichment of sequences of interest in both genic
and intergenic regions. To this end, we recently implemented
methylC-capture sequencing (MCC-Seq) for targeted assessment
of DNA methylation in a tissue-speciﬁc manner (Allum et al.
2015). This approach has been particularly useful for the analysis
of intermediate levels (20–80%) of methylation, or dynamic sites,
that are postulated to be susceptible to environmental exposures
(Ziller et al. 2016). Using this approach, we showed that DNA
methylation variation linked to disease traits is enriched within
intergenic and enhancer-associated regions, with such regions
characterized by intermediate levels of methylation (Allum et al.
2015). With sperm possessing unique epigenetic patterns, diﬀering dramatically from those of somatic cells, ascertaining and targeting the susceptible/variable regions of the sperm DNA
methylome, in addition to genic regions, would aid in more eﬃciently assessing the eﬀect of environmental exposures.
The goal of the current study was to identify regions of variable and/or dynamic DNA methylation in human sperm, to use
this information to design a customized human sperm methylation
capture panel for DNA methylation proﬁling, and then to test it in
sperm samples of men exposed to low or high levels of methyl
donors through either perturbations in folate metabolism or high
doses of folic acid supplements, respectively. To accomplish this,
we ﬁrst generated a human sperm WGBS data set that diﬀered
from the published one (Molaro et al. 2011) by examining a sperm
Environmental Health Perspectives

DNA sample pooled from a wide cross section of 30 men in order
to represent common epigenetic diversity. Using the data, we then
designed a targeted human sperm-speciﬁc MCC-Seq panel. We validated the approach by assessing the impact of the common 5,10methylenetetrahydrofolate reductase (MTHFR) 677C > T polymorphism and response of high-dose folic acid supplementation on
DNA methylation of human sperm in diﬀerent cohorts of men. This
customized panel can be used to accurately assess sperm DNA methylation proﬁles at single CpGs, with enriched coverage targeting putative environmentally susceptible sequences in human sperm.
Improvements in our ability to examine sperm DNA methylation
following diﬀerent environmental impacts (i.e., toxicants, exposures, stressors) may optimize assessment of the risks associated
with alterations to the germline epigenome and the subsequent
health of future generations.

Methods
Sample Collection
In order to capture/introduce variability in sperm DNA methylation, a group of 39 men, representing diverse subtypes, varying
by fertility status, age, smoking status, MTHFR genotype, and folic acid use, were selected. Participants were recruited from three
Canadian cities. From Toronto, 24 healthy normospermic male
participants were recruited from the Canadian Reproductive
Assisted Technology (CReATe) fertility clinic and provided a
single semen sample. These men were considered fertile given
that they had normal sperm parameters (Cooper et al. 2010) and
that the couple presented to the clinic due to known female factor
infertility; indeed, 67% (16/24) of the participants had achieved a
previous pregnancy. The Toronto samples were chosen to introduce diversity through diﬀering MTHFR genotypes, smoking status, and, at least in part, those who had previously fathered
children. Twelve men from the Montreal area were selected from
the McGill University Reproductive Centre or the OVO Clinic.
Although the Montreal participants were normospermic, they
were considered idiopathic infertile because their partners had no
known causes for female infertility. The 12 individuals from
Montreal, after consulting with their andrologists, received highdose folic acid supplementation (5 mg=d), and sperm samples
were collected prior to and within 1 week following 6 months of
supplementation. These samples were chosen to include diﬀering
MTHFR genotypes, use of folic acid supplements, and idiopathic
infertility. Finally, three additional participants of unknown fertility status were recruited from the Ottawa Fertility Clinic; these
men were included due to their advanced age. In all cohorts,
semen samples were collected by masturbation following a recommended 3-day minimum of abstinence. Following semen
liquefaction (20–30 min at room temperature), an aliquot was
taken for sperm counts and the rest of the sample was immediately frozen at −80 C. Informed consent was obtained from all
participants. The study was approved by all respective research
and ethics boards.

DNA Isolation and MTHFR Genotyping
Sperm were lysed in a buﬀer containing a ﬁnal concentration of
150 mM Tris, 10 mM ethylenediaminetetraacetic acid, 40 mM dithiothreitol, 2 mg=mL proteinase K, and 0.1% sarkosyl detergent
and were incubated overnight at 37°C. DNA was then extracted
using the QIAamp® DNA Mini kit (Qiagen) according to the
manufacturer’s protocols. The common single nucleotide polymorphism, MTHFR 677C > T, was genotyped from all sperm
DNA samples using polymerase chain reaction (PCR)–restriction
fragment length polymorphism, as originally described by Frosst
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et al. (1995) and detailed by Sener et al. (2014). Brieﬂy, following DNA ampliﬁcation, a PCR product of 198 bp in size is produced. Presence of the MTHFR 677C > T polymorphism creates
a Hinf I restriction cut site; when cleaved, this results in fragments of 175 and 23 bp, that can be visualized through gel
electrophoresis.

Bisulfite Pyrosequencing
We screened sperm DNA samples for possible somatic cell contamination through bisulﬁte pyrosequencing of the imprinting
control regions (ICRs) for H19 imprinted maternally expressed
transcript (H19) and mesoderm-speciﬁc transcript (MEST), a
paternally and maternally methylated imprinted gene, respectively, on all subjects. As well, this technique was used to validate diﬀerentially methylated cytosines (DMCs) found to be
altered following analysis of human sperm capture sequencing
data (see below). Here, primers were designed to overlap the
areas where diﬀerential methylation was observed (i.e., intron 4
of sterile alpha motif domain containing 11 (SAMD11) and an
intergenic region). For the validation, pyrosequencing results
from ﬁve participants from each the MTHFR 677CC and 677TT
groups were compared with their associated human sperm capture panel results. The average methylation between genotypes,
as well as individual patient’s methylation data, was compared
with the average/same patient’s capture sequencing data.
For all pyrosequencing assays, 500 ng of sperm DNA underwent bisulﬁte conversion with the EpiTect® bisulﬁte kit (Qiagen)
according to the manufacturer’s protocol. Bisulﬁte PCR was conducted using primers (see Excel Table S1) and pyrosequencing
was performed as previously described (Dejeux et al. 2009).
Brieﬂy, regions of interest were PCR ampliﬁed with one of the
primers being biotinylated. Capture of the biotinylated strand was
performed with streptavidin-coated sepharose beads and washed
using the PyroMark® Q24 Vacuum Workstation (Qiagen). A
sequencing primer was annealed to the isolated captured template
strand and the pyrosequencing reaction was conducted using the
PyroMark® Q24 kit (Qiagen) as per the manufacturer’s protocol.
For somatic cell contamination, sperm DNA samples were
considered not to be contaminated if methylation across all analyzed CpGs in both imprinted genes did not deviate from the
expected high levels of methylation for H19 (>90%) and low levels for MEST (<10%) (Kläver et al. 2013). All samples in the
current study met the criteria for lack of somatic cell contamination, and thus no sperm DNA samples were excluded (Table 1).

WGBS and Targeted Capture Sequencing
WGBS and targeted bisulﬁte sequencing were performed as previously described (Allum et al. 2015; Cheung et al. 2017). To
examine the variability in human sperm DNA methylation, a subset of the men (total 30 participants; Table 1) was chosen in order
to produce a single WGBS library pool (WGBS-Pool). A subset
of the total of 39 men was chosen in order to ensure suﬃcient
depth of sequencing from all participants in the single WGBS
library. More speciﬁcally, samples (total n = 30) were chosen to
reﬂect diﬀering MTHFR genotypes and smoking status from the
Toronto cohort (n = 21); MTHFR 677TT genotype, idiopathic
infertility and folic acid supplementation use from the Montreal
cohort (n = 6); and advanced aged from the Ottawa cohort
(n = 3). Equal amounts of sperm DNA from these 30 participants
were combined in order to make the pooled sperm DNA sample
used. The WGBS-Pool library was constructed using the KAPA®
High Throughput Library Preparation kit (Roche/KAPA®
Biosystems). Brieﬂy, 1 lg of the sperm DNA was spiked with
0.1% (w/w) unmethylated k and pUC19 DNA (Promega). DNA
Environmental Health Perspectives

Table 1. Demographics of participants for the pooled human sperm WGBS
(WGBS-Pool) library.
Characteristics
Age
Mean
Range
Imprinted gene methylation
H19 (mean, range)
MEST (mean, range)
Fertility statusa
Fertile
Infertile
Unknown
Sperm counts (million/mL)
Mean
Range
Percentage DFI (%)
Mean
Range
Smoking status (n)
Smokers
Nonsmokers
Unknown
MTHFR genotype (n)
MTHFR CC
MTHFR CT
MTHFR TT
High-dose folic acid use [5 mg=d (n)]
Yes
No

n, mean ± SD, and/or range
41:4 ± 9:1 y
27–61 y
97:1 ± 0:8%, 94:5–97:9%
4:2 ± 1:0%, 2:7–6:2%
21
6
3
100:8 ± 95:6 (n = 29)b
3.8–497.7
15:0 ± 7:1 (n = 26)b
6.05–30.9
6
23
1
13
2
15
6
24

Note: DFI, DNA fragmentation index; MTHFR, methylenetetrahydrofolate reductase;
SD, standard deviation; WGBS, whole genome bisulfite sequencing.
a
A fertile status was determined if participants were normospermic and presented to the
clinic due to known female factor infertility (see “Methods” section).
b
Sperm counts and %DFI were not measured in all individuals due to limited amount of
sample available upon collection.

was sonicated (S220 Focused-ultrasonicator, Covaris) and fragment sizes of 300–400 bp were controlled on a Bioanalyzer DNA
1000 LabChip® (Agilent). Following fragmentation, DNA-end
repair of double-stranded DNA breaks, 3 0 -end adenylation, adaptor ligation, and clean-up steps were conducted according to
KAPA® Biosystems’ protocols. The sample was then bisulﬁte
converted using the EpiTect® Fast DNA bisulﬁte kit (Qiagen) following the manufacturer’s protocol. The resulting bisulﬁte DNA
was quantiﬁed with OliGreen® (Life Technology) and ampliﬁed
with 9–12 PCR cycles using the KAPA® HiFi HotStart Uracil +
DNA Polymerase kit (Roche/KAPA® Biosystems) according to
suggested protocols. The ﬁnal WGBS library was puriﬁed using
Agencout® AMPure® Beads (Beckman Coulter), validated on
Bioanalyzer High Sensitivity DNA LabChip® kits (Agilent) and
quantiﬁed by PicoGreen® (ThermoFisher).
Targeted bisulﬁte sequencing was performed on the same 30participant pooled sperm DNA sample used for WGBS (CapturePool) to compare the technique as well as on 45 individual samples (Table 2). These samples were chosen in order to examine
the eﬀect of MTHFR genotype alone from the Toronto cohort
(MTHFR 677CC n = 13, 677TT n = 8), and to examine the eﬀect
of folic acid supplementation and MTHFR genotype on a cohort
of idiopathic infertile men from Montreal (n = 6 per genotype,
before and after supplementation; i.e., 24 total samples). Following WGBS library preparations for all individual samples (as
described above), the MCC-Seq protocol developed and optimized by Roche NimbleGen® was applied. Brieﬂy, the SeqCap®
Epi Enrichment System protocol (Roche NimbleGen®) was used
to capture the regions of interest. Equal amounts of multiplexed
libraries (84 ng of each, 12 samples per capture) were combined
to obtain 1 lg of total input library, which was hybridized to
the capture panel at 47°C for 72 h. Washing, recovery, and PCR
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Table 2. Demographics of samples assessed with the human sperm capture panel.
Cohort
Characteristic
Total number of participants (n)
Age
Mean ± SD
Range
Fertility statusa
Sperm counts (million/mL)
Mean ± SD
Range
Percentage DFI (%)
Mean ± SD
Range
Smoking status (n)
Smokers
Nonsmokers
MTHFR genotype (n)
MTHFR CC
MTHFR TT
High-dose folic acid use [5 mg=d (n)]
Yes
No

Toronto

Montreal, pre-folic acid

Montreal, post-folic acid

n, mean ± SD, or range

n, mean ± SD, or range

n, mean ± SD, or range

21

12

12

40:8 ± 8:6 y
28–61 y
Fertile

39:3 ± 8:2 y
26–53 y
Infertile

39:3 ± 8:2 y
26–53 y
Infertile

73:2 ± 29:0
38.0–140.0

188:2 ± 174:5
27.5–536.5

203:0 ± 208:0
46.9–674.8

15:0 ± 6:7
6.1–30.9

22:5 ± 9:6
7.7–39.42

18:2 ± 7:6
7.64–27.6

6
15

0
12

0
12

13
8

6
6

6
6

0
21

0
12

12
0

Note: DFI, DNA fragmentation index; MTHFR, methylenetetrahydrofolate reductase; SD, standard deviation.
a
A fertile status was determined if participants were normospermic and presented to the clinic due to known female factor infertility (see “Methods” section).

ampliﬁcation of the captured libraries, as well as ﬁnal puriﬁcation were conducted as recommended by the manufacturer.
Bioanalyzer High Sensitivity DNA LabChip® kits (Agilent)
were used to determine quality, concentration, and size distribution of the ﬁnal captured libraries.
The single WGBS-pool library was sequenced over four lanes
using the Illumina® HiSeq2000 system, whereas the capture libraries were sequenced over eight lanes on the Illumina® HiSeq4000
system. All sequencing used 100-bp paired-end sequencing.

Sequencing Data Processing
WGBS HiSeq reads were aligned to the bisulﬁte-converted reference genome hg19/GRCh37 using BWA (version 0.6.1) (Li and
Durbin 2009). Low-quality sequences (Phred score < 30) were
trimmed from the 3 0 end of paired reads. Following alignment,
read-pairs not mapped at the expected distance based on the
library insert size, as well as reads a) that were clonal/duplicates,
b) with low mapping quality, c) mapping to both forward and
reverse strands, and d) with >2% mismatches were removed, as
previously described (Johnson et al. 2012). Individual CpG methylation calling was extracted using SAMtools (version 0.1.18) in
mpileup mode.
Targeted MCC-Seq HiSeq reads were aligned using an in-house
GenAP_pipe pipeline (https://bitbucket.org/mugqic/genpipes).
Speciﬁcally, the MCC-Seq paired-end raw reads were ﬁrst trimmed for quality (Phred 33 ≥ 30), length (n ≥ 50), and Illumina®
adapters using Trimmomatic (version 0.36) (Bolger et al. 2014).
The trimmed reads were then aligned, per sequencing lane, to the
pre-indexed reference genome hg19/GRCh37 using Bismark (version 0.18.2) (Krueger and Andrews 2011) with Bowtie 2 (version
2.3.1) (Langmead and Salzberg 2012) in pair-end mode and default
parameters. Lane BAM ﬁles were merged and then de-duplicated
using Picard (Broad Institute, version 2.9.0). Methylation calls were
obtained using Bismark. BisSNP (version 0.82.2) (Liu et al. 2012)
was run on the de-duplicated BAM ﬁles to call variants. For both
WGBS and MCC-Seq data, CpGs that were found to be overlapping with SNPs (dbSNP 137), the Data Analysis Center (DAC)
Blacklisted Regions or Duke Excluded Regions [both generated by
Environmental Health Perspectives

the Encyclopedia of DNA Elements (ENCODE) project] were
removed. CpG sites with less then 20 × coverage were also discarded and genomic locations were annotated with HOMER, using
default parameters. Sequencing data from WGBS and from MCCSeq have been submitted to the European Genome-phenome
Archive under the accession number EGAS00001003617.

Comparison with Other Human Sperm WGBS Data
Our WGBS-Pool data were compared with publically available
data on human sperm from [Molaro et al. 2011 (GSE3040;
WGBS-Prev)] where sperm DNA methylation data from two
anonymous donors were pooled after sequencing. The processed
data were downloaded (reference genome hg18) and were converted to the reference genome hg19 using the University of
California, Santa Cruz (UCSC) Genome Browser tool Batch
Coordinate Conversion (liftOver). Similar to our data, only sites
with ≥20 × coverage were used for analysis. For the comparison
of common sites between the two data sets (WGBS-Pool vs.
WGBS-Prev), the intersectBed feature of bedtools (version
2.27.0) was used to select overlapping sites.

Statistical Analyses
Generalized linear regression models (GLMs) were built using
the methylation proportion inferred from the combination of
methylated reads and unmethylated reads as a binomially distributed response variable to look for associations between DNA
methylation and a) MTHFR genotype (e.g., MTHFR 677CC vs.
MTHFR 677TT) or b) high-dose folic acid supplementation (e.g.,
before vs. after). We used the R function glm (R Development
Core Team, version 3.2.1) and the binomial family to ﬁt the
model, and calculated p-values for variables of interest. We corrected the obtained p-values by generating false discovery proportion q-values using the R package q-values (Chung and Storey
2015). We selected signiﬁcant DMCs as q or nominal p ≤0:01,
with a minimum of methylation level diﬀerence of ≥10%.
Speciﬁcally, for the comparison of MTHFR genotype (Toronto
cohort; 677CC: n = 13, 677TT: n = 8), results were signiﬁcant for
q ≤0:01 and a minimum methylation diﬀerence of 10%. For the
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eﬀect of folic acid supplementation in the Montreal cohort (n = 6
per genotype, per time point), due to the relatively smaller sample
size, signiﬁcant results were reported for nominal p ≤ 0:01 and a
minimum methylation diﬀerence of 10%.
Graphs were made and statistical analyses performed using
GraphPad Prism (version 6.01), and statistical signiﬁcance was set
at p < 0:05 for the analyses described below. Absolute values were
compared by Fisher’s exact test, when comparing smoking and
alcohol consumption distributions among participants. t-Tests
were performed to compare the age (unpaired), serum/red blood
cell (RBC) folate levels (paired), and overall sperm DNA methylation levels (paired) between MTHFR genotypes or pre/post-folic
acid supplementation. Unpaired t-test and analysis of variance
(ANOVA) was used in examining DNA methylation variation.
Enrichment of diﬀerent publically available data sets was compared between the total number of sites analyzed through our
human sperm capture panel and the diﬀerent folate metabolism–
related DMCs using v2 test with Yates’ correction.

Results
Deep WGBS on a Pooled Sperm DNA Sample
We assembled an equimolar pool of sperm DNA from a subset of
the participants recruited (30 men) varying in age, fertility status,
MTHFR genotype, and exposures (folic acid supplements, smoking) (Table 1). By having such a wide cross section of men, we
wished to assess the variation in human sperm DNA methylation
caused by having a complex pool of sperm DNA. The men came
from three Canadian cities: a) Toronto, a fertile cohort; b)
Montreal, an idiopathic infertility cohort; and c) Ottawa, an aged
cohort (see Excel Table S2). Imprinted gene methylation was
assessed by bisulﬁte pyrosequencing to assess sample purity
and rule out samples with somatic cell contamination (i.e.,
abnormal imprinted gene methylation aﬀected equally across
all imprinted gene loci); all samples were accepted because
they each showed the expected methylation for sperm with
>90% methylation at the paternally methylated H19 locus and
<10% methylation at the maternally methylated MEST locus
(Table 1). A single WGBS library from the 30 men (WGBSPool) was prepared and sequenced to a depth of 1,672,735,160
raw reads, yielding an average CpG coverage of 23 × , which
corresponded to an average genome-wide methylation of 74.1%
(see Excel Table S3). Over 95% of CpG dinucleotides had
sequence coverage (Figure 1A).
Comparing our WGBS-Pool with a previous WGBS data set
looking at human sperm DNA methylation from two individual
participants (WGBS-Prev; Molaro et al. 2011), we covered 1.7times more CpG sites at ≥20 × coverage (Figure 1B,C). The average methylation of the highly covered sites was found to be
80.5% and 69.4% for our WGBS-Pool and WGBS-Prev, respectively (Figure 1B, table). This diﬀerence in methylation may be
explained by the fact that a greater proportion of highly covered
sites from the WGBS-Prev was found within promoter–transcriptional start site (TSS) regions as well as within CpG islands
(Figure 1B, bottom); these features generally show hypomethylation and would therefore reduce the overall DNA methylation.
Although the WGBS-Pool data sequenced more CpG sites at high
coverage, comparing the methylation of common sites with the
published data demonstrated similar DNA methylation levels
(Figure 1C,D); a total of 5,395,997 common CpGs were sequenced
and showed a strong correlation (r = 0:93). When examining the
diﬀerence in methylation of the common/overlapping sites
between the two data sets, a large majority of the CpGs (5,022,176
sites; 93.1%) demonstrated congruent/similar (<10% diﬀerence)
methylation (Figure 1E, shaded bars) and displayed mainly low
Environmental Health Perspectives

(≤20%) or high (≥80%) levels of methylation. Conversely, divergent CpGs, where a >10% methylation diﬀerence between data
sets was observed (373,821 sites; open bars), demonstrated mainly
intermediate levels of methylation, between 20% and 80%.
Because our WGBS-Pool was generated from DNA from 30
individuals, creating a complex pool, we hypothesized that sites
of intermediate methylation would contain sites of dynamic
methylation due to variability in sperm methylation states (intraand inter-individual). Interestingly, in a recent study using blood
and adipose tissue, it was demonstrated that environmental diﬀerentially methylated regions (DMRs) possess intermediate methylation, outside of the hypomethylated promoter areas (Busche
et al. 2015). Techniques, such as RRBS, interrogate high-CpG
density sequences, which normally show relatively stable hypomethylation (Figure 2A, left panel; data from Aarabi et al.
(2015). In line with this, we found from our WGBS-Pool data
(Figure 2A, right) that a signiﬁcant proportion of CpGs possessing 0–20% methylation mapped within promoter-TSS regions
(deﬁned as −1 kb to + 100 bp from TSS), which tend to harness
low variation (Figure 2B, Low). More speciﬁcally, 74.6% of all
CpGs found within promoter-TSS regions within the genome
possessed <20% methylation. Our data also demonstrated that
the large majority of sequenced CpGs possessed methylation
between 80% and 100% (Figure 2A, right panel). Intermediatelevel methylation (i.e., 20–80%) was observed in the WGBSPool for 2.01 million CpGs, as compared with 0.26 and 1.75
million sites from RRBS and WGBS-Prev, respectively (Figure
2C); these intermediate sites were concentrated to intergenic
CpGs as well as sites in intronic regions, and both areas contained distal sequences that can regulate gene activity (Figure
2B, Intermediate).

Sperm Methylation Capture Design for MCC-Sequencing
We designed a capture panel targeting regions of intermediate
methylation in human sperm as a cost-eﬃcient alternative to shotgun WGBS. Speciﬁcally, in order to target regions of intermediate levels of methylation, sliding windows of 150 bp bins,
containing a minimum of two consecutive CpGs, were constructed using our WGBS-Pool data. The methylation levels of
each bin were calculated, sorted and binned regions with a minimum absolute diﬀerence from the 50% methylation level were
retained (250,000 bins above and below); overlapping bins were
further merged. In addition, to allow comparisons with human
sperm DNA methylation proﬁles generated by us and others using
Illumina® arrays (Aston et al. 2015; Chan et al. 2017; Jenkins et al.
2014, 2017; Krausz et al. 2012), the complete set of CpGs from
the 850K array (n ∼850,000) was added. Upstream and downstream 50-bp ﬂanking regions were added to each individual probe
location and were then added to those determined through our
WGBS data, with overlapping regions merged.
Our design for the human sperm methyl capture yielded
107:14 Mb of sequence targetable by Roche NimbleGen® for synthesis of a custom SeqCap® Epi probe panel, containing 830,188
regions capturing 3,179,096 CpG sites. These targeted sites were
found mainly in a) intergenic (34%), intronic (33%), and promoterTSS (19%); b) CpG island; and c) nonrepetitive regions and were
dispersed throughout the genome (Figure 3A; see also Figure
S1A). Of the ∼3:18 million CpG sites on the human sperm capture
panel, 937,141 sites represented those derived from our WGBSPool data possessing regions of intermediate methylation (i.e. intermediate methylation captured CpGs); the remainder represented
850K-derived sites (Figure 3B).
Comparing the human sperm methyl capture with other techniques available, we noted that the commercially available
TruSeq® Methyl Capture EPIC (EPIC capture) from Illumina®
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targets a similar DNA sequence footprint and total number of
CpG sites, although fewer regions (Figure 3B). The largest diﬀerences are observed for intermediate methylation captured CpG
sites captured, and although these constitute approximately onethird of our human sperm capture panel, they represent a small
proportion of the sites analyzed with the 850K array or the EPIC
capture (5.2% and 3.8% of sites, respectively) (Figure 3B, bottom
and Figure S1B). Notably, the intermediate methylation captured
CpGs sites are found mainly in intergenic and outside of CpGdense areas of the genome, whereas CpG sites covered by the
other techniques include a greater proportion of promoter-TSS
regions and CpG islands (see Figure S1C). EPIC-related CpGs
Environmental Health Perspectives

not sequenced by our human sperm methyl capture panel, were
mainly found in repetitive elements and immediately ﬂanking
CpG-dense areas in the EPIC design (see Figure S2). Finally, as
compared with microarray technologies, the capture sequencing
allowed for the measurement of genetic in parallel with epigenetic variation (see below and the “Methods” section).

Variation in DNA Methylation in Intermediate Methylation
Captured CpG Sites
We hypothesized that the intermediate methylation captured
CpGs sites on our human sperm capture panel, derived from our

087002-7

127(8) August 2019

A

1

Intron
Intergenic
3
Promoter-TSS
4
Exon
5
TTS
6
3' UTR
7
5' UTR
8
Non-coding

1

2 3

2

1

2

3

4

8
76
5
B

1

1

Island
Shore
3
Shelf
4
Open Sea

2

3

Methylation850
TruSeq Methyl
Capture EPIC

4

2

4

Technique
Sperm Methyl
Capture

5
6
7
8

1

CpG Sites

Regions

Footprint

3,179,096

830,188

107.14 Mb

863,905

N/A

N/A

3,353,173

437,792

107.40 Mb

Non-Repeat
LINE
3
SINE
3
LTR
5
DNA
61
Low_complexity
7
Simple_Repeat
8
Other
2

Sperm Methyl
Capture
MethylationEPIC
TruSeq Methyl
Capture EPIC
0

5

10

15

20

25

30

35

Number CpGs (105)

“Intermediate” methylation CpGs
C

Total CpGs
11.1 million
3.13 million
E

100

Other EPIC-related CpGs

Coverage
8.3 fold
18.5 fold

60.7 %
46.7 %
25
20

80

Frequency (104)

WGBS - Pool % Methylation

D

Capture - Pool
All Sequenced CpGs
On Target CpG

850K derived CpGs

60
40
20
767,417 sites
R2 = 0.9682

0
0

20

40

60

80

15
10
5
0

100

-100

Capture - Pool % Methylation

-50

0

50

100

% Methylation Difference

Figure 3. Creation and validation of the human sperm capture panel. (A) Sites captured by the human sperm capture panel analyzing their distribution by
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WGBS-Pool data, would represent sites with dynamic methylation. In other words, these sites would demonstrate higher variability in methylation compared with other sites sequenced. To
test this, the panel was used to capture and sequence 45 individual
Environmental Health Perspectives

human sperm samples (21 individuals from Toronto and 12 individuals with two time points from Montreal, discussed further
below). Examining only sites targeted and sequenced with ≥20 ×
coverage in at least 30 of the 45 participants, we calculated the
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standard deviation of each CpG. As shown in Figure S3, the intermediate methylation captured CpG sites (n = 571,584) had signiﬁcantly higher average variation ( ∼5-fold) compared with
850K-derived sites found on our capture panel (n = 1,104,764).
Because the numbers of sites diﬀered between the intermediate
methylation captured and 850K-derived CpGs, we randomly chose
subsets of the 850K-derived CpGs in order to obtain similar numbers (permutated ﬁve times); the results were similar, with intermediate methylation captured CpGs demonstrating signiﬁcantly
greater variation. With these results, hereafter, we denote intermediate methylation captured CpGs as dynamic sperm CpG sites.

Validation with Targeted Sequencing of Pooled Sperm DNA
In order to validate the use of the human sperm capture panel, the
same pooled sperm DNA used for the WGBS-Pool was sequenced
following targeted capture (Capture-Pool). We observed a minimum of 1 × coverage at a total of 11.1 million CpGs (average
8:3 × ) (Figure 3C). A large proportion of these CpGs sequenced
were found in regions not intentionally targeted by our panel due
to nonspeciﬁc/oﬀ-target capture of other genomic sequences; these
sites are covered at low depth and demonstrated an average coverage of 4:2 × (see Figure S4A). By contrast, we saw enrichment of
our targeted sites where 3.13 million CpGs (>98% of targets) were
sequenced, demonstrating an intermediate methylation (46.7%) at
an elevated average coverage of 18:5 × (Figure 3C; see also Figure
S4B).
Comparing common sites sequenced from the WGBS-Pool
and Capture-Pool data, 767,417 CpG sites were sequenced at a
minimum 20 × coverage using both techniques and showed a correlation of r = 0:97 (Figure 3D). Examining the diﬀerence in methylation detected between the two sequencing methods, greater than
75% of common sites demonstrated <10% methylation diﬀerence
between the techniques; at a level of 20% diﬀerence in methylation, 95% of common sites were included (Figure 3E). In addition,
the sequencing coverage aﬀected the correlation particularly at
dynamic sperm CpG sites (see Figure S4C). When examining sites
speciﬁcally targeted by our human sperm capture panel, from our
deep sequencing of the WGBS-Pool, we obtained approximately
22:7 × coverage for these sites from over 1.67 billion reads (see
Excel Table S3). In comparison with our Capture-Pool targeted
sequencing, with only a little over 46.5 million reads, we obtained
a similar coverage of targeted sites (18:6 × ). Thus, targeted CpGs
were equally covered at only 3.4% raw data depth of the shotgun
WGBS, improving cost-eﬃciency for population studies.

MCC-Sequencing in Sperm from Individual Men
We next utilized the human sperm methyl capture panel to assess
the eﬀect of two diﬀerent, yet related, perturbations of folate metabolism: a) samples from the Toronto fertile cohort, to examine
the eﬀect of MTHFR genotype; and b) participants from the
Montreal infertile cohort, to examine the interaction of MTHFR
genotype and high-dose folic acid supplementation (before vs. after; Table 2). Speciﬁcally, a diﬀerent subset of sperm from 21 men
from the CReATE fertility clinic in Toronto was used. Because
they presented at the clinic due to known female factor infertility,
they were considered to be fertile. As well, 12 healthy normospermic participants were used from the Montreal cohort, where semen
samples were collected before and after a folic acid supplementation (i.e., a total of 24 samples); this subset of participants was previously analyzed using RRBS (Aarabi et al. 2015). These men
presented with idiopathic infertility given that female factor infertility was excluded. Although a signiﬁcant diﬀerence in sperm
counts was observed between the Toronto and Montreal cohorts
(Table 2), all men analyzed with the human sperm capture (45
Environmental Health Perspectives

men in total) were considered normospermic because they met the
criteria according to WHO guidelines (>15 × 106 sperm=mL;
Cooper et al. 2010). This diﬀerence in sperm counts may be due to
methodology or counting biases used at the diﬀerent sites.
Principal component analysis (PCA) was performed for all
the individual libraries based on genotyping data extracted from
the methylome sequencing (see “Methods” section; see also Figure
S4D). Given that <10% of the variance can be explained by the
ﬁrst two principal components (PC1 = 4:75% and PC2 = 4:05%),
the genetic ancestry of the participants is comparable and would
not be considered a confounder. Similar to the Capture-Pool
library preparation, on average approximately 12:2 ± 0:58 million
CpGs were sequenced at a minimum 1 × coverage, whereas targeted regions showed an enrichment of highly covered CpGs (average 3:14 ± 0:0038 million CpGs at 27:6 ± 3:72-fold coverage;
see Figure S4E and Excel Table S3).

Imprinted Gene DNA Methylation Patterns from Targeted
Sequencing
We examined in greater detail the sperm DNA methylation patterns at several imprinted genes because abnormal sperm DNA
methylation patterns at imprinted loci have previously been
observed in men suﬀering from infertility (Kobayashi et al. 2009;
Li et al. 2013; Poplinski et al. 2010). Figure 4 depicts regions of
two imprinted genes, H19 and MEST, and shows the methylation
of highly covered CpG sites from an individual CC and TT
patient (CC and TT genotype tracks, respectively). On inspection
of the imprinted loci and their ICRs, we observed that the 850K
array interrogated only a subset of the CpG sites found within the
regions. This can be seen particularly at the paternally methylated
H19 ICR (Figure 4A), where only two 850K-array probes are
located (850K track), compared with the human sperm capture,
where 17 sites are targeted (Capture CpG track). As with many
maternally methylated ICRs, the MEST ICR is found within a CpG
island and is well covered with the diﬀerent assays (Figure 4B).
Earlier bisulﬁte pyrosequencing of these imprinted loci examined only a few sites within the ICR of two imprinted genes
(5 and 10 CpG sites for H19 and MEST, respectively). The highdensity data (17 and 126 sites for H19 and MEST, respectively)
obtained using the human sperm capture panel on the 45 individual samples demonstrated no signiﬁcant MTHFR genotype- or
folic acid-dependent variation in these and other ICRs (see
Figure S5). Although no diﬀerences were found in ICR methylation, a DMR could be observed just upstream of the H19 promoter when comparing MTHFR genotypes of two individual
subjects (Figure 4A, shaded area).

Impact of Lifelong MTHFR Deficiency on Sperm DNA
Methylation
The ﬁrst phenotypic correlations we carried out using the human
sperm capture panel interrogated the eﬀect of a common human
functional polymorphism in MTHFR on sperm DNA methylation
given that we have previously demonstrated that functional Mthfr
variation in mice is a global sperm methylation modiﬁer (Aarabi
et al. 2018). In mice, MTHFR is expressed at higher levels in the
testis than any other tissue (Chen et al. 2001). Because MTHFR
677TT individuals have a genetic deﬁciency that results in a thermolabile form of the enzyme with ∼50% of residual activity
(Kang et al. 1991), they have the equivalent of a lifelong MTHFR
deﬁciency; such deﬁciency could impact DNA methylation patterning in the fetal or postnatal testis. Here, sperm from 13
MTHFR 677CC and 8 677TT fertile men from Toronto were analyzed (mean genome coverage of 29:1 × and 29:2 × , respectively). Both groups were similarly distributed based on age
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Figure 4. Examination of imprinted gene methylation from human sperm capture sequencing data. UCSC Genome Browser view of the imprinting control centers
(ICRs, green regions) of (A) the paternally methylated gene H19, and (B) the maternally methylated gene MEST. Custom tracks indicate CpG sites (green), CpGs
analyzed by Inﬁnium MethylationEPIC array (black), TruSeq® Methyl Capture EPIC (blue), our human sperm Capture (gold), and Dynamic CpG sites (light
green). Tracks for representative capture sequencing data (all sequenced sites with >20 × coverage are shown) for a CC individual (red) and a TT individual (dark
green) are shown. As compared with the gold tracks, which show only on-target CpGs (of a total of 3.13 million; see Figure 3C), more CpG sites are marked in
the CC and TT tracks as sites sequenced at >20 × coverage are shown (of a total of 11.1 million as shown in Figure 3C). Note: chr, chromosome; CpG,
5 0 -cytosine-phosphate-guanine-3 0 ; DMR, diﬀerentially methylated region; ICR, imprinting control region; UCSC, University of California, Santa Cruz; CDDS,
consensus coding sequence.

(41:8 ± 10:0 y and 39:1 ± 6:0 y), smoking (4 of 13 and 2 of 8 participants) and alcohol consumption (3 of 13 and 2 of 8 participants,
for 677CC and TT, respectively). Figure S6A shows Q-Q and
Manhattan plots of association p-values for tested sites. From
these, a total of 13,428 DMCs were found to be signiﬁcantly
altered due to MTHFR genotype, at a false discovery rate of
q ≤ 0:01 and a minimum of 10% diﬀerence in methylation, and
were found mainly in intergenic and intronic regions of the genome
(Figure 5A). A greater number of sites were found to have increased
methylation in MTHFR 677TT compared with MTHFR 677CC men
(8,756 hyper- vs. 4,672 hypomethylated DMCs; Figure 5B,C).
Interestingly, a vast majority (86.7%) of the DMCs discovered were
those shown to be dynamic sperm CpG sites, uniquely targeted in
our assay. DMCs were commonly annotated to the same gene/
region within the genome and predominantly found clustered together (see Excel Table S4). Examples include several intergenic
regions, the promoter and ﬁrst exon/intron of the noncoding RNA
Environmental Health Perspectives

LOC100130872, and within the introns of SAMD11, transcription
elongation factor B polypeptide 3C-like (TCEB3CL), and disks
large-associated protein (DLGAP2). The diﬀerential methylation of
several DMCs was validated using bisulﬁte pyrosequencing: An
intron of SAMD11 (5 CpGs; Figure 5D) and an intergenic region (4
CpGs; Figure 5E) demonstrated excellent concordance in DNA
methylation between bisulﬁte pyrosequencing and human sperm
capture panel results. Inter-individual variability between participants within each group was observed and also validated (see Figure
S7 and Excel Table S5).
The MTHFR 677TT genotype-associated diﬀerences in methylation are reminiscent of those we reported in mice heterozygous
for a targeted mutation in Mthfr, a model for MTHFR deﬁciency
similar to that found in MTHFR 677TT men (Aarabi et al. 2018).
Our previous sperm DNA methylation data generated with RRBS
were reanalyzed to generate individual CpG data. Similar to the
present results, the majority of the DMCs were found in intergenic
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Figure 5. Eﬀect of MTHFR genotype, in Toronto cohort men, on sperm DNA methylation. Total number of DMCs between human MTHFR 677CC (n = 13)
and 677TT (n = 8) genotypes with their (A) genomic region distribution, (B) demonstrating mainly hypermethylation and changes in dynamic sperm CpG sites,
and (C) diﬀerences in methylation between genotypes. Pyrosequencing® validation of several DMCs found within (D) an intron of SAMD11 and (E) an intergenic region. Mean ± standard error. Note: chr, chromosome; CpG, 5 0 -cytosine-phosphate-guanine-3 0 ; DMCs, diﬀerentially methylated cytosines; hyper, hypermethylated; hypo, hypomethylated; MTHFR, methylenetetrahydrofolate reductase; SAMD11, sterile alpha motif domain containing 11; TSS, transcriptional
start site; TTS, transcriptional termination site; UTR, untranslated region.

and intronic regions (see Figure S6B) and revealed hypermethylation in Mthfr + = − mice compared with their wild-type littermates
(Figure S6C,D); 8,549 DMCs were found to have an increased
level of methylation in Mthfr + = − mice, whereas 407 sites showed
decreased levels.

Impact of Short-Term Folic Acid Exposure on Sperm DNA
Methylation
We selected a subset of men (n = 6 MTHFR 677CC and n = 6
MTHFR 677TT) who had also been examined earlier by us using
RRBS (Aarabi et al. 2015), and we used the human sperm methyl
capture panel to analyze the eﬀect of 6 months of treatment with
high-dose folic acid supplements (5 mg=d) on sperm DNA methylation. Six months of folic acid supplement treatment covers two
rounds of spermatogenesis and can be considered a short-term perturbation of folate metabolism when compared with the long-term
(lifelong) eﬀect of MTHFR genotype described above. All men in
this cohort were nonsmokers, and were equally distributed based
on age (36:5 ± 6:5 y and 42:4 ± 8:0 y for 677CC and TT,
Environmental Health Perspectives

respectively); alcohol consumption was not recorded for this
cohort. Serum and RBC folate levels were previously measured
(Aarabi et al. 2015), and reanalysis of the subset of men used in
our present study demonstrated similar results, where no diﬀerences between MTHFR genotype were observed; however, elevated
serum (see Figure S8A) and RBC (see Figure S8B) folate levels
were observed following supplementation. We compared group
eﬀects of supplementation on DNA methylation in both MTHFR
genotypes separately (see Figure S9A,B). Because of the small
number of participants with each genotype, sites were nominated
to be diﬀerentially methylated with p ≤ 0:01 and a minimum of
10% diﬀerence in methylation. Similar to our previous results,
the overall sperm DNA methylation from each MTHFR genotype was not aﬀected following high-dose folic acid supplementation (677CC: 46:24 ± 0:30% and 46:36 ± 0:54%; 677TT:
46:12 ± 1:54% and 45:84 ± 1:23%, baseline and following supplementation, respectively). However, supplementation resulted in
4,039 and 7,301 DMCs in the MTHFR 677CC and 677TT
groups, respectively, and were distributed similarly in terms of
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genotype, 40% of DMCs (5,384 sites) remained as isolated CpG
sites (Figure 7A, left). Combining DMCs within 50 bp resulted
in 2,450 merged regions, with the largest found to be 417 bp
(Figure 7A, right). In contrast, the use of folic acid supplementation for both MTHFR 677CC and 677TT groups showed that
many of the altered DMCs remained as individual CpG sites (92%
and 84%, respectively; Figure 7B,C, respectively); only 188 (maximum 69 bp) and 495 (maximum 121 bp) merged regions were
discovered, respectively. The largest 10 merged regions from each
comparison are listed in Excel Table S8. Thus, folic acid supplementation resulted in fewer and smaller merged regions.
The stark contrast between the eﬀects of MTHFR genotype
eﬀect vs. high-dose folic acid supplementation can be observed in
Figure 8. MTHFR 677TT subjects showed higher levels of methylation compared with MTHFR 677CC subjects within the seventh
intron of DLGAP2 (Figure 8A). Here, six regions (ranging from a
single CpG site to 109 bp in size) were found encompassing 25
DMCs showing 15–20% hypermethylation due to the MTHFR
677C > T polymorphism. Interestingly, all the altered sites were
found to be dynamic sperm CpGs. Examining the eﬀect of folic
acid supplementation in MTHFR 677TT subjects, the largest DMR
(121 bp in size) was found within the ﬁrst intron of epidermal
growth factor receptor (EGFR) and contained four dynamic sperm
CpG sites demonstrating decreased methylation (12–20% loss) after supplementation.

genomic regions (Figure 6A; see also Excel Tables S6 and
S7). The 677CC genotype was associated with a slight tendency for increased DNA methylation (2,343 hyper- and 1,696
hypomethylated DMCs; Figure 6B). Similar to our reported
RRBS ﬁndings, men with the MTHFR 677TT genotype showed
a signiﬁcantly higher proportion of hypomethylated sites in
sperm (p ≤ 0:0001, v2 test with Yates’ correction); 4,765 sites
demonstrated loss, whereas 2,535 sites showed increases in
methylation. Similar to genotype eﬀects seen in the Toronto
samples, approximately 80% of DMCs for both genotypes
were discovered to be dynamic sperm sites. In addition, paralleling MTHFR genotype eﬀects, altered methylation was found
close to or within SAMD11 and DLGAP2 following folic acid
supplementation in both 677CC and 677TT subjects
To ensure low sampling bias (comparing our earlier larger
RRBS study to the current proof-of-principle capture study),
we restricted the comparison of RRBS and human sperm capture panel results to the same 12 MTHFR 677CC and 677TT
individuals included in both studies. We observed convergence
of measured eﬀects by the independent methods: 677TT men
being more aﬀected than 677CC men and also having a greater
loss of sperm DNA methylation following supplementation
(see Figure S9C). Gene ontology (GO) analysis, using DMCs
found within genes, identiﬁed an enrichment of biological
processes related to nervous system development and neuron
diﬀerentiation for MTHFR 677CC and 677TT genotypes in
both the human sperm capture panel data (Figures 6C,D,
respectively) and the reanalysis of RRBS data (see Figure
S9D,E, respectively).

Functional Correlates of Folate Metabolism–Related
Differential DNA Methylation
Finally, it is possible that the folate metabolism–associated
altered sperm DNA methylation relates to functional or sensitive
areas in the genome. We therefore determined whether the
DMCs or the merged regions we identiﬁed overlapped with putative functional regions from published studies. Although some
overlap was found with histone modiﬁcations, evolutionarily constrained elements, and conserved sperm DNA methylation patterns, no enrichment was seen above background of the human
sperm capture panel (see Figure S10A–F).
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We next examined whether sites or regions would be similarly aﬀected following diﬀerent perturbations or exposures.
Within our present results, few DMCs/regions overlapped when
comparing eﬀects of MTHFR genotype vs. those of folic acid
supplementation. Interestingly, few altered DMCs were in common between MTHFR 677CC and 677TT subjects following folic
Environmental Health Perspectives

acid supplementation (see Figure S10H). WGBS was recently used
to assess the eﬀect of serum dioxin concentrations on the sperm
DNA methylome. Again, few regions intersected with the DMCs
found in our current study (see Figure S10G). Although there
appears to be no speciﬁc susceptible regions in human sperm DNA
methylation, exposure-speciﬁc signatures may be present.
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Discussion
We applied WGBS on a population pooled sperm DNA sample to
develop a targeted capture panel for the analysis of variable human
sperm DNA methylation. This human sperm methyl capture panel
not only targets the commonly assessed gene promoter/CpG island
regions but also captures novel dynamic sperm DNA methylation
sites at innocuous putative distal regulatory elements. These
dynamic sperm sites represented the majority of CpGs diﬀering in
methylation levels between individuals with altered one-carbon
metabolism (MTHFR deﬁciency) and those given high-dose folic
acid supplements.
Several targeted capture panels have been designed including
those that examine the DNA methylome across diﬀerent cells and
tissues (Ziller et al. 2016) and those that are more tissue-speciﬁc,
for instance, an adipose tissue–targeted panel (Allum et al. 2015).
The sperm epigenome, with its low retention of histones (<15% in
humans) (Hammoud et al. 2009, 2014) and specialized DNA methylome (Ziller et al. 2013), diﬀers greatly from that of other cell
types, indicating that development of a customized sperm panel is
Environmental Health Perspectives

warranted. The approach we chose to use, in order to discover variable regions in the sperm DNA methylome, utilized a pool of
sperm DNA from a diverse group of men. Although we were able
to cover nearly twice as many CpG sites at ≥20 × coverage, our
new human sperm WGBS data set compared well with the published WGBS data set from two normospermic men (Molaro et al.
2011), especially for sites with methylation levels <20% or >80%.
In contrast, CpG sites where DNA methylation diﬀered by >10%
between the two WGBS data sets were mostly found to possess intermediate levels of methylation (20–80%). In addition, with our
WGBS-Pool data set we were able to identify about 260,000 more
novel sites of intermediate methylation, likely due to interindividual variation in the pooled discovery cohort, compared with
RRBS (Aarabi et al. 2015) or other WGBS data on single/two
pooled samples (Molaro et al. 2011). Our results underscore the
importance of assessing population as well as tissue lineagedictated diﬀerences in epigenetic landscapes.
Our customized sperm capture design incorporated the regions
of intermediate methylation identiﬁed by WGBS, which were
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found to be more variable than other CpG sites targeted and were
denoted as dynamic sperm CpGs. These sites represented roughly
a third of the ∼3:18 million targeted CpGs; in contrast, <5% of
dynamic sperm CpGs are detected by the 850K array or EPIC
Capture. Using the WGBS-pool sample to test our capture panel
allowed us to conﬁrm that the panel we designed was able to accurately, and at high coverage, capture close to 100% ( ∼3:13 million)
of the targeted CpGs. Moving on to individual samples, the sperm
capture results recapitulated DNA methylation levels of genes,
such as imprinted genes, that have been well studied in sperm.
Folate metabolism is important for the synthesis of nucleic
acid precursors and amino acids and the production of S-adenosylmethionine (SAM), the universal methyl donor (Bailey et al.
2010). It is therefore not surprising that polymorphisms in
MTHFR, a crucial enzyme within this pathway, would lead to
altered DNA methylation. With our capture panel, participants
homozygous for the 677C > T polymorphism demonstrated
altered sperm DNA methylation, with a greater tendency for hypermethylation. This is in line with our previous animal study
demonstrating increased sperm DNA methylation in mice haploinsuﬃcient for the Mthfr gene and considered a model for
MTHFR 677TT individuals (Aarabi et al. 2018). A large proportion of the observed changes were found to be dynamic sperm
sites and would not have been detected with other currently available techniques. Furthermore, many of the sites altered due to genotype were increases in sperm DNA methylation. Altered
methyl pools and SAM due the MTHFR 677TT variant may aﬀect
other epigenetic marks, such as H3K4 methylation. Particularly,
H3K4me3 is anticorrelated with DNA methylation (Ooi et al.
2007); therefore, decreases in this histone modiﬁcation may have
resulted in increased levels of DNA methylation at speciﬁc sites.
The human sperm methyl capture panel was also used to
reevaluate the eﬀect of high-dose folic acid supplementation on a
cohort of infertile participants (Aarabi et al. 2015). Use of folic
acid resulted in altered DNA methylation patterns in sperm, dependent on the participants’ MTHFR genotype. A greater tendency for hypermethylation was observed in MTHFR 677CC
subjects, whereas signiﬁcant hypomethylation was seen in those
homozygous for the T allele. Results here, along with similar
results from our previous human and animal model studies, provide further support for our proposal that high circulating and testicular folate levels down-regulate MTHFR, decreasing methyl
group availability and leading to loss of DNA methylation
(Aarabi et al. 2018). Here, we again discovered that the vast majority of sites with altered methylation, after short-term use of
high-dose folic acid supplements, were dynamic sperm CpGs.
Along with infertility, the MTHFR 677C > T polymorphism
has been associated with cancer, vascular, neurological, and psychiatric diseases (Liew and Gupta 2015). MTHFR 677TT subjects
were found to have signiﬁcantly increased methylation at several
CpG sites/regions within SAMD11 and DLGAP2. SAMD11 has
been found to be a strong candidate gene for autism spectrum disorders through a whole exome sequencing study (Chapman et al.
2015). Similarly, in an animal model of post-traumatic stress disorder caused by an environmental stress, speciﬁc hypermethylation
within Dlgap2 and decreased expression were associated with the
eﬀects of a traumatic environmental stressor (Chertkow-Deutsher
et al. 2010). High-dose folic acid supplementation also resulted in
altered methylation around these two genes, although only at a few
CpG sites. Interestingly however, GO analysis from both MTHFR
677CC and 677TT individuals showed enrichment in biological
processes involving neurogenesis following supplementation.
In addition to enrichment for GO analysis, we examined
other functional aspects of the altered sites found in our study.
It has been reported, so far, that histone retention in sperm is
Environmental Health Perspectives

found predominantly at promoters, which are hypomethylated
(Brykczynska et al. 2010; Hammoud et al. 2009, 2014); thus,
it would not be expected to show great enrichment in our data.
Along similar lines, a large proportion of constrained elements, often indicating regions of functional importance, are
found mainly in known exons, as well as 5 0 and 3 0 untranslated
regions (UTRs) (Davydov et al. 2010), regions showing little
alterations in sperm DNA methylation following perturbations. Finally, it has been reported that an evolutionary expansion of hypomethylated regions in the genome was found (Qu
et al. 2018); the majority of DMCs we discovered were within
dynamic sperm sites, possessing intermediate levels of methylation; therefore, no enrichment was observed as well.
A diﬀerential response was observed between our diﬀerent
perturbations to folate metabolism. We discovered that men
homozygous for the MTHFR 677C > T polymorphism demonstrated a larger number of DMCs when compared with MTHFR
677CC individuals; altered sites detected were found within close
proximity, resulting in regions of diﬀerential methylation. An
altered sperm DNA methylome due to MTHFR genotype is the
result of a persistent/lifelong perturbation given that the polymorphism was present since fertilization. The highest enzyme activity of MTHFR in mice was observed in the testes (Chen et al.
2001), and studies from our lab have demonstrated that protein
expression was detected in pre- and postnatal mouse germ cells
(Garner et al. 2013). Speciﬁcally, in mice, the expression of
MTHFR was detected at the highest levels during the major time
of DNA methylation acquisition (embryonic day 15–18; Garner
et al. 2013). Therefore, the observed results may be due to a lifetime altered methyl pool availability and SAM, particularly during in utero development, causing disruptions during male germ
cell DNA methylation pattern establishment over larger regions
in the genome.
Although genotypic diﬀerences of MTHFR examined lifelong
perturbations, the eﬀects seen in our supplementation study
reﬂect short-term/acute perturbations. Subjects within this group
were given high-dose folic acid supplementation for a 6-month
period. This timeframe only covers approximately two rounds of
spermatogenesis and sperm maturation. With this limited window
of exposure, we did not expect to see as many dramatic and consistent changes in sperm DNA methylation. Indeed, fewer altered
DMCs were observed following folic acid supplementation and
few neighboring sites were combined to create regions of diﬀerential methylation. Studying longer exposures to folic acid supplements and/or examining whether any alterations in the sperm
methylome persist following the cessation of supplements, would
allow us to determine the reversibility of any changes and
whether perturbations aﬀect stem cells, resulting in permanent
alterations. Nonetheless, this modest exposure altered the sperm
DNA methylome in a manner that could be detected, thereby
demonstrating the sensitivity of both the sperm methylome and
the human sperm capture panel.
As mentioned previously, a vast majority of the sites altered
in methylation were found to be the dynamic sperm CpGs and
would not have been detected with many of the commercially
available techniques. Whether these dynamic sites are more
likely to be aﬀected following other types of exposures in adult
men requires further study. Indeed, studies that have examined
the eﬀect of diﬀerent environmental stressors and/or factors—
such as smoking (Jenkins et al. 2017), cannabis use (Murphy et al.
2018), obesity (Donkin et al. 2016), phthalates (Wu et al. 2017b),
BPA (Tian et al. 2018), childhood abuse (Roberts et al. 2018), and
even exercise (Denham et al. 2015)—have demonstrated alterations in human sperm DNA methylation. All but one of these studies (Tian et al. 2018) used diﬀerent versions of Illumina®’s
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methylation array or RRBS. The use of the human sperm capture
panel would allow the targeting of many of these same regions,
with the added beneﬁt of analyzing sites of dynamic methylation,
at high coverage and not requiring full and costly assessment of
the entire sperm DNA methylome. Examining how the risk of different environmental exposures aﬀects the sperm DNA methylation is of great importance given that these germ cells can
inﬂuence the health of future generations.
In addition to strengths of our study, there are several limitations. The greatest limitation is the small sample size of patients.
Although in observational studies, large cohort sizes are expected,
our motivation was to test the applicability of our human capture
panel to experimentally detect previously studied alterations due to
perturbations in one-carbon metabolism and the folic acid pathway. Although patient numbers in each of our experimental groups
were low, we were able to obtain results similar to previous studies
in animal models (MTHFR genotype eﬀect) and from larger patient
numbers (folic acid eﬀects), demonstrating the suitability of our
human sperm capture panel to detect alterations in sperm DNA
methylation. Some patient characteristics that could aﬀect the
sperm DNA methylome, such as BMI, were not known for our participants, something that is worth following up in future studies
using our sperm capture panel. Age may also aﬀect the sperm
DNA methylome and represents another factor that should be
examined in more detail with our approach in a larger cohort of
men. Another limitation of our study is the inability of bisulﬁte
sequencing to distinguish between 5-methylcytosine (5mC) and 5hydroxymethylcytosine (5hmC). 5mC can be actively demethylated through ten-eleven translocation mediated oxidation to 5hmC
and has been found to be important in the epigenetic reprograming of germ cells in mouse and humans (Hackett et al. 2013; Tang
et al. 2015; Yamaguchi et al. 2013). Although 5hmC is found at
several orders of magnitude less than 5mC in sperm, recent studies relying on immunoﬂuorescence (Eﬁmova et al. 2017),
enzyme-linked immunosorbent assay (ELISA) (Jenkins et al.
2013), and immunoprecipitation followed by sequencing (Zheng
et al. 2017) have found altered amounts of 5hmC in sperm due to
semen quality, age, and exposures to bisphenol A, respectively.
It would be interesting to determine the impact of diﬀerent exposures on both 5mC and 5hmC levels through oxidative bisulﬁte
sequencing (Booth et al. 2013), which can be amenable to capture sequencing.
Our pooled approach for developing customized tools for epigenome variability, in a tissue-targeted manner, addresses speciﬁc variation in the human sperm epigenome. With our human
sperm methylation capture panel, we discovered diﬀerential
DNA methylation following conditions aﬀecting folate metabolism, most of which was found to be in novel dynamic sperm
CpG sites. Our customized panel allows for accurate assessment
of sperm DNA methylation proﬁles at single CpGs with an unprecedented coverage, targets putative environmentally sensitive
sequences in human sperm and improves our ability to examine
environmental impacts on DNA methylation in human sperm.
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